Clinical trial · Interventional
Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors
Development and Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Objectives: This project aims to develop a self-management program for survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy and determine its effectiveness. Methods: The investigators will develop a self-management program and conduct a study on survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy. And the investigators will test the effectiveness of the self-management program. After completing a pretest, participants will be randomly assigned to the experimental or control group. The self-management group will receive the self-management program for 12 weeks, whereas the information group will receive an information package on a healthy diet. Posttests will be administered 12 and 16 weeks after the pretest. The study variables will include physical symptoms and bothers, cancer-related self-efficacy, social participation, demoralization, and resilience.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostatic Neoplasms | Prostate Neoplasm | ALIAS | 0.90 |
| Self-Management | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Information package | Other | — | UNRESOLVED |
| Self-management program | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Self-management group
- description
- The experimental group will receive the self-management program for 12 weeks.
- interventionNames
- Behavioral: Self-management program
- type
- OTHER
- label
- Information group
- description
- The control group will receive an information package on a healthy diet.
- interventionNames
- Other: Information package
Primary outcomes (3)
- measure
- Cancer related self-efficacy
- timeFrame
- Pre-test
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: Prostate cancer survivors will include if they fit the following: * Received radical prostatectomy and suffering from urinary incontinence for at least one week * Eastern Cooperative Oncology Group 0-1 point, able to walk entirely independently * Have a smartphone or a tablet with a wireless network * Their intimate partner or one of the family members willing to learn together * Agreed to participate in the study and completed the informed consent form Exclusion Criteria: Prostate cancer survivors will be excluded if they had one or more of the following: * A request, with the consideration of family members, that the medical team not tell the patient about the diagnosis or condition of the disease * A history of psychiatric illness, such as dementia, depression; schizophrenia, or bipolar disorder * Suffer from other types of cancer and actively undergoing treatment
References
Publications (26)
- BACKGROUNDChien CH, Liu KL, Wu CT, Chuang CK, Yu KJ, Lin PH, Huang XY, Pang ST. Development and assessment of a self-management intervention for urinary incontinence among patients with prostate cancer: protocol for a randomized feasibility study. BMC Urol. 2023 Nov 18;23(1):193. doi: 10.1186/s12894-023-01367-7. PMID 37980490
- BACKGROUNDAgochukwu NQ, Skolarus TA, Wittmann D. Telemedicine and prostate cancer survivorship: a narrative review. Mhealth. 2018 Oct 8;4:45. doi: 10.21037/mhealth.2018.09.08. eCollection 2018. PMID 30505843
- BACKGROUNDAn E, Lo C, Hales S, Zimmermann C, Rodin G. Demoralization and death anxiety in advanced cancer. Psychooncology. 2018 Nov;27(11):2566-2572. doi: 10.1002/pon.4843. Epub 2018 Aug 20. PMID 30053317
- BACKGROUNDBaker H, Wellman S, Lavender V. Functional Quality-of-Life Outcomes Reported by Men Treated for Localized Prostate Cancer: A Systematic Literature Review. Oncol Nurs Forum. 2016 Mar;43(2):199-218. doi: 10.1188/16.ONF.199-218. PMID 26906131
- BACKGROUNDBandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977 Mar;84(2):191-215. doi: 10.1037//0033-295x.84.2.191. No abstract available. PMID 847061
- BACKGROUNDCampbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilience. J Trauma Stress. 2007 Dec;20(6):1019-28. doi: 10.1002/jts.20271. PMID 18157881
- BACKGROUNDChien CH, Chuang CK, Liu KL, Huang XY, Liu HE. Psychosocial adjustments in patients with prostate cancer from pre-diagnosis to 6 months post-treatment. Int J Nurs Pract. 2016 Feb;22(1):70-8. doi: 10.1111/ijn.12360. Epub 2014 Oct 13. PMID 25307968